Companies / Monopar Therapeutics Inc.

Monopar Therapeutics Inc.

Nasdaq: MNPRCIK 1645469WILMETTE, IL

Financials ยท FY2025

Revenue$0
Net income$-13.72M
Total debtโ€”
Cash$52.76M
Diluted EPSโ€”
Shares outstanding6.7M

Ownership

6.7M shares outstanding ยท as of Jul 31, 2026
3.0%Insiders
Ownership
Insiders2.97%199,259
Institutions83.17%5,582,436
Public float13.86%930,477

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all โ†’
Insider% of sharesShares
Robinson ChandlerCEOChief Executive Officer ยท Director
2.21%148,533
Cittadine AndrewChief Operating Officer
0.76%50,726
Rioux Patriceโ€”
โ€”โ€”
Rodriguez SusanCCSO
โ€”โ€”

Institutional holders 76

View all โ†’
HolderValue% of shares
Janus Henderson Group PLC$72.06M19.63%
RA Capital Management, L.P.$36.56M9.94%
BlackRock, Inc.$32.30M5.20%
Saturn V Capital Management LP$21.27M4.85%
Vanguard Group Inc$19.19M4.38%
Deerfield Management Company, L.P.$17.74M4.82%
Adage Capital Partners Gp, L.L.C.$16.94M4.61%
ADAR1 Capital Management, LLC$15.27M3.48%
Wellington Management Group LLP$14.76M3.37%
Siren, L.L.C.$13.86M3.16%

Activity

Jun 30, 2026View all โ†’
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ฮ”Position afterImpact
Q1 2026
as of
Adage Capital Partners Gp, L.L.C.
13F manager
TrimCommon Stock$-18.10M-330K
-51.65%
309,195
4.61% of shares
medium
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$8.70M+94K
+36.87%
348,819
5.20% of shares
medium
Q1 2026
as of
Deerfield Management Company, L.P.
13F manager
AddCommon Stock$8.39M+153K
+89.82%
323,745
4.82% of shares
medium
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
AddCommon Stock$5.73M+105K
+327.63%
136,443
2.03% of shares
medium
Q2 2026
as of
Deutsche Bank AG
13F manager
AddCommon Stock$2.56M+28K
+819.30%
31,008
0.46% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
TrimCommon Stock$-1.30M-24K
-30.94%
52,951
0.79% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$792.8K+9K
+10.19%
92,551
1.38% of shares
low
Q1 2026
as of
Bank of New York Mellon Corp/The
13F manager
AddCommon Stock$754.0K+14K
+21.22%
78,618
1.17% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
RA Capital Management, L.P.Passive13G/Aโ€”โ€”โ€”
AstraZeneca PLCPassive13G/Aโ€”โ€”โ€”

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MNPRCommon StockEquity61023L207BBG00J7K8D90